E2902: A Phase III randomized study of farnesyl transferase inhibitor R115777 in acute myeloid leukemia patients in second or subsequent remission or in remission after primary induction failure or patients over age 60 in first remission
Clinical Advances in Hematology and Oncology H&o 5(1): 13-14
2007
ISSN/ISBN: 1543-0790 PMID: 17339821 Document Number: 610168
Document emailed within 1 workday
Related Documents
Piccaluga, P.Paolo.; Martinelli, G.; Malagola, M.; Rondoni, M.; Bianchini, M.; Visani, G.; Baccarani, M. 2003: Complete remission in acute myeloid leukemia with granulocyte-colony stimulating factor without chemotherapy. Report of cytogenetic remission of a t(9;11)(p22q23) positive AML patient and review of literature Haematologica 88(8): Ecr28Anderlini, P.; Ghaddar, H.M.; Smith, T.L.; Pierce, S.; Kantarjian, H.M.; O'Brien, S.; Keating, M.J.; Freireich, E.J.; Estey, E.H. 1996: Factors predicting complete remission and subsequent disease-free survival after a second course of induction therapy in patients with acute myelogenous leukemia resistant to the first Leukemia 10(6): 964-969
Vats, T.S.; Lui, V.; Trueworthy, R.; van Eys, J. 1981: Phase Ii clinical trial of dianhydrogalactitol for remission induction in children with acute leukemia: a Southwest Oncology Group Study Cancer Treatment Reports 65(1-2): 121-122
Cetkovsky, P.; Koza, V.; Cepelák, V.; Vít, L. 1994: The influence of induction chemotherapy and remission status on haemostasis in patients treated for acute myeloid leukaemia Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 5(3): 349-353
Del Potro, E.; Díaz Mediavilla, J.; Martínez, R.; Alvarez, A.; Krsnik, I.; Guerra, J.L.; Llorente, L.; López, J.C.; Díaz Morfa, M.; Villegas, A. 1989: Remission induction treatment in adults with acute myeloid leukemia. 8-year experience with 2 successive protocols Medicina Clinica 92(16): 601-604
Kisliak, N.S.; Chernov, V.M.; Kondratchik, K.L.; Pronina, L.K.; Stolov, A.M. 1994: Duration of the first remission and survival rate of children with acute lymphoblastic leukemia after use of thymus preparations in the remission period Gematologiia i Transfuziologiia 39(5): 43-44
Shalaev, V.A.; Gushcha, A.A. 1989: Clinical significance of the immunocompetence of patients with acute leukemia in the remission phase Gematologiia i Transfuziologiia 34(4): 27-30
Laila, R.; Islam, A.; Bhuiyan, M.M. 2016: Incidence of Hyperglycemia during Induction of Remission Phase of Pediatric Acute Lymphoblastic Leukemia Mymensingh Medical Journal: Mmj 25(4): 730-735
Löwenberg, B.; Abels, J.; van Bekkum, D.W.; Dzoljic, G.; Hendriks, W.D.; van der Poel, J.; Sizoo, W.; Sintnicolaas, K.; Wagemaker, G. 1983: Transplantation of autologous bone marrow in 3 patients with acute myeloid leukemia in first remission; initial experiences with a new treatment Nederlands Tijdschrift Voor Geneeskunde 127(30): 1329-1332
Saito, M.; Ino, T.; Shigemura, H.; Shimizu, S.; Matsui, T.; Ono, Y.; Nakamura, K.; Okamoto, M.; Takada, T.; Imura, H. 1985: Clinical evaluation of cases of remission induction failure in acute myelogenous leukemia Gan to Kagaku Ryoho. Cancer and ChemoTherapy 12(3 Part 1): 554-560
Lorenzo, J.I.; Sanz, M.A.; Martín-Aragonés, G.; Rafecas, F.J.; Martínez, J.A.; Sanz, G.; Gomis, F. 1988: Prognostic factors and predictive models of the different causes of failure in te induction of remission in acute nonlymphoblastic leukemia Medicina Clinica 90(4): 151-155
Frassoni, F.; Martinelli, G.; Saglio, G.; Sessarego, M.; Podestà, M.; Piaggio, G.; Farabegoli, P.; Zaccaria, A.; Testoni, N.; Remiddi, C. 1995: bcr/abl chimeric transcript in patients in remission after marrow transplantation for chronic myeloid leukemia: higher frequency of detection and slower clearance in patients grafted in advanced disease as compared to patients grafted in chronic phase Bone Marrow Transplantation 16(4): 595-601
Kawashima, K.; Nagura, E.; Yamada, K.; Hamajima, N. 1986: Primary relapse in patients with acute leukemia after an initial 5-year period of complete remission Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 49(7): 1354-1359
Ohashi, H.; Ichikawa, A.; Takagi, N.; Hotta, T.; Naoe, T.; Ohno, R.; Saito, H. 1992: Remission induction of acute promyelocytic leukemia by all-trans-retinoic acid: molecular evidence of restoration of normal hematopoiesis after differentiation and subsequent extinction of leukemic clone Leukemia 6(8): 859-862
Gale, R.P.; Cline, M.J. 1977: High remission-induction rate in acute myeloid leukaemia Lancet 1(8010): 497-499
Hołowiecki, J.; Duraj, M.; Rudzka, E.; Jarczok, K.; Krawczyk, M.; Hołowiecka, B.; Kniewska, I.; Kuśnierczyk, J.; Opala, G.; Stańczuk, M. 1984: Cooperative randomized studies on the treatment of adult acute leukemia in Poland. a comparison of two remission induction regimes and two maintenance regimes for AML Folia Haematologica 111(2): 201-207
Kiersnowska-Rogowska, B.; Parfieńczyk, A.; Rogowski, F. 2004: Blood levels of the adhesion molecules ICAM-1 and VCAM-1 in patients with chronic myeloid leukemia during remission and exacerbation Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 16(93): 240-244
Smith, F.O.; Raskind, W.H.; Waldron, P.; Steinmann, L.J.; Matsushita, M.; Singer, J.W.; Lampkin, B.C.; Woods, W.G.; Lange, B.J.; Hammond, G.D. 1993: Clonal remission in childhood acute myeloid leukemia is an infrequent event Leukemia 7(7): 929-932
Larson, R.A.; Lukin, C.L.; Daly, K.M.; Mick, R.; Gore, S.; Le Beau, M.M. 1991: Circulating immune complexes correlate with remission duration in acute myeloid leukemia Leukemia 5(2): 131-137
Bassan, R.; Barbui, T. 1995: Remission induction therapy for adults with acute myelogenous leukemia: towards the ICE age? Haematologica 80(1): 82-90